Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page .
BTIG raised Hudson Pacific Properties, Inc. (NYSE: HPP ) price target from $4.75 to $26. BTIG analyst Thomas Catherwood maintained a Buy rating. Hudson Pacific Properties shares closed at $10.83 on Wednesday. See how other analysts view this stock. Ascendiant Capital increased the price target for NRx Pharmaceuticals, Inc. (NASDAQ: NRXP ) from $47 to $48. Ascendiant Capital analyst Edward Woo maintained a Buy rating. NRx Pharmaceuticals shares closed at $2.71 on Wednesday. See how other analysts view this stock. HC Wainwright & Co. cut Corcept Therapeutics Incorporated (NASDAQ: CORT ) price target from $145 to $90. HC Wainwright & Co. analyst Swayampakula Ramakanth maintained a Buy rating. Corcept Therapeutics shares closed at $34.80 on Wednesday. See how other analysts view this stock . Barclays raised the price target for Vertiv Holdings Co (NYSE: VRT ) from $181 to $200. Barclays analyst Julian Mitchell upgraded the stock from Equal-Weight to Overweight. Vertiv shares closed at $162.01 on Wednesday. See how other analysts view this stock. Stephens & Co. raised the price target for Digi International Inc. (NASDAQ: DGII ) from $50 to $55. Stephens & Co. analyst Tommy Moll maintained an Overweight rating. Digi International shares closed at $43.29 on Wednesday. See how other analysts view this stock. Canaccord Genuity cut Bioceres Crop Solutions Corp. (NASDAQ: BIOX ) price target from $2.25 to $2. Canaccord Genuity analyst Austin Moeller maintained a Hold rating. Bioceres Crop Solutions shares settled at $1.31 on Wednesday. See how other analysts view this stock . Stephens & Co. raised Glaukos Corporation (NYSE: GKOS ) price target from $115 to $145. Stephens & Co. analyst George Sellers maintained an Overweight rating. Glaukos closed at $112.91 on Wednesday. See how other analysts view this stock. Argus Research raised Ulta Beauty, Inc. (NASDAQ: ULTA ) price target from $650 to $700. Argus Research analyst Deborah Ciervo maintained a Buy rating. Ulta Beauty shares closed at $605.01 on Wednesday. See how other analysts view this stock . Canaccord Genuity cut the price target for Corcept Therapeutics Incorporated (NASDAQ: CORT ) from $140 to $99. Canaccord Genuity analyst Edward Nash maintained a Buy rating. Corcept Therapeutics shares settled at $34.80 on Wednesday. See how other analysts view this stock . Jefferies raised Baidu, Inc. (NASDAQ: BIDU ) price target from $159 to $181. Jefferies analyst Thomas Chong maintained a Buy rating. Baidu shares closed at $130.66 on Wednesday. See how other analysts view this stock .Considering buying ULTA stock? Here’s what analysts think:
BIDU Baidu Inc $145.20 11.1% Overview BIOX Bioceres Crop Solutions Corp $1.30 -0.76% CORT Corcept Therapeutics Inc $35.30 1.44% DGII Digi International Inc $43.29 -% GKOS Glaukos Corp $112.91 -% HPP Hudson Pacific Properties Inc $10.83 -% NRXP NRX Pharmaceuticals Inc $2.76 1.85% ULTA Ulta Beauty Inc $607.01 0.33% VRT Vertiv Holdings Co $168.91 4.26% Market News and Data brought to you by Benzinga APIs© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Add Comment | 1Posted In: News Price Target Pre-Market Outlook Markets Analyst Ratings Trading Ideas analysts forecasts PT Changes